Ref.: BL-RE-091894Manufacturer ref.: EMSERPINE1X5 5 x 96 tests
€2,950.00 excl. VAT
Kit ELISA PAI-1 sandwich (SERPINE1) (mouse): quantitative determination of Ms PAI-1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms PAI-1.
Accession number
P22777
Dose range
81.92 pg/ml to 20.000 pg/ml
Sensitivity of the dosage
80 pg/ml
Calibration range
80 pg/ml to 20 000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA PAI-1 sandwich (SERPINE1) (mouse): quantitative determination of Ms PAI-1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms PAI-1.
Kit ELISA PAI-1 sandwich (SERPINE1) (mouse): quantitative determination of Ms PAI-1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms PAI-1.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
PAI1 (plasminogen 1 activator inhibitor) belongs to the superfamily of serine protease inhibitor and is the main inhibitor of tissue-type and urokinase-type plasminogen activators (tPA and uPA). Platelets are the main source of circulating PAI11, but are synthesized and secreted by many types of tissues and cells, including fibroblasts, smooth muscle cells, endothelial cells, hepatocytes and inflammatory cells. The expression of PAI11 can be regulated at the transcriptional level by many factors, including growth factors, cytokines, hormones, inflammatory factors, glucose or lipid metabolites, vascular tone control factors, chemicals, and other environmental or physical factors. IAP1 is present at increased levels in various disease states, and has been associated with an increase in the occurrence of thrombosis in obesity, thrombophilia and metabolic syndrome. IAP-1 defects are characterized by abnormal bleeding. PAI1 media inhibition of fibrinolysis by inhibiting the activity of plasminogenic activator and may promote neuronal survival. Other PAI1 defects are the cause of a deficiency in plasmanogen 1-inhibitor (PAI-1). Alternative splicing transcription variants that code different isoforms of PAI1 have also been found.
Sensitivity
Sensitivity of dosage: 80 pg/ml.
Measurement range
Dose range: 81.92 pg/ml to 20.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
This pair of antibodies used by ELISA detects human and mouse PAI-1.